FFF Enterprises Celebrates 26 Years of Safety, Innovation

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
FFF Enterprises Celebrates 26 Years of Safety, Innovation and Growth

TEMECULA, Calif., July 8, 2014 (GLOBE NEWSWIRE) -- FFF Enterprises, Inc., the nation's largest and most trusted distributor of plasma products, vaccines and other specialty pharmaceuticals and biopharmaceuticals celebrates its 26th anniversary on July 8, 2014. With a focus on safety and innovation, FFF takes a proactive approach to helping its customers ─ both healthcare providers and their patients ─ navigate the dynamic and changing healthcare landscape.

"Since our inception, our goal has always been to get the critical-care products we distribute from the manufacturer to the patient in the most efficient, streamlined way possible, minimizing the complexity for our customers and maximizing patient safety," says Patrick M. Schmidt, chief executive officer, FFF Enterprises, Inc.

Headquartered in Temecula, Calif., FFF serves customers across the nation, with a majority on the East Coast. To expand its capacity to serve more customers, FFF is preparing to open a second distribution facility in Kernersville, N.C. Slated to house 164 new team members; the North Carolina location will also feature a NuFACTOR Specialty Pharmacy, allowing FFF to ship products for same business day delivery anywhere in the country.

"It became mandatory for us to expand our center of operation," says Schmidt. "As we looked to the future, it became apparent that we needed multiple sites that are prepared to handle 100 percent of our business for an extended period of time in the event of a natural disaster. Business continuity is essential for any company, but when you are dealing with critical-care products, there are lives hanging in the balance."
As FFF continues to grows, so does the range of customers it serves. Earlier this year, the company signed a new contract that will improve access to specialty medications for select hospitals and patients, and extend FFF's reach in the specialty pharmaceutical business, which is projected to grow to approximately $400 billion by 2020.

FFF has also invested in technology as part of the company's strategic growth plan. In late 2013, the company launched its inventory management program, Verified Inventory Program-Consignment (VIPc). VIPc utilizes advanced RFID technology to continuously monitor product inventory and automatically replenish stock as it is used. The system also eliminates carrying costs, and invoices customers only when products are used.
Founded in 1988 with $100 and a vision to distribute patient examination gloves, FFF's annual sales today approach $1 billion, and its partners include the largest and most influential GPOs, serving over 80 percent of U.S. hospitals and supplying the nation's leading non-acute care sites.
Almost from the start, FFF set out to reshape the biopharmaceutical industry by making the supply chain safer for patients. FFF's mission, "Helping Healthcare Care," is epitomized by other innovative technologies such as its Verified Electronic Pedigree (VEP)™ system, which electronically displays the chain of custody for every product it ships, and its Lot-Track™ service, which tracks products by lot number and provides recall notification to those affected. The company's foresight also led to the development of a best practices business model dubbed "The 8 Critical Steps to Guaranteed Channel Integrity™."

FFF's patient-centered focus resonates through its specialty pharmacy subsidiary, NuFACTOR, which provides immune globulin, coagulation factors and vaccines directly to patients. Other innovative programs include MyFluVaccine and VaxAmerica which provide revolutionary approaches to vaccine access and administration.

About FFF Enterprises, Inc.

FFF Enterprises is the largest and most trusted distributor of plasma products, vaccines and other specialty pharmaceuticals and biopharmaceuticals in the U.S. Founded in 1988, FFF is now in its 27th year with more than a billion dollars in annual sales and a flawless safety track record. FFF has taken a leadership position in regard to supply chain safety and innovation, setting new standards and pioneering industry firsts. FFF's commitment to Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to healthcare providers, with additional steps taken to safely store, handle and ship products to ensure patient safety is never compromised. Together with its Verified Inventory Program-Consignment (VIPc)™ that provides real-time inventory management utilizing advanced RFID technology, FFF's proprietary systems, Verified Electronic Pedigree™ and Lot-Track™, provide verification of FFF's secure channel. In addition, FFF's MyFluVaccine ( www.MyFluVaccine.com ) and VaxAmerica ( www.VaxAmerica.com ) are revolutionary vaccination programs that have added a new level of safety, convenience and reliability for both healthcare providers and consumers.
 

Brian D. Miller, Vice President, Marketing and Communications (951) 296-2500, ext 1357

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 537

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 262

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 400

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 403

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 425

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 54

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 349

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 340

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 512

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

DoubleLine Income Solutions Fund Announces Upcoming Dividend

Updated Category News Views 125

DoubleLine Income Solutions Fund Announces Distribution The DoubleLine Income Solutions Fund, symbolized as DSL on the New York Stock Exchange, has recently declared a distribution of $0.11 per share for the upcoming month. This announcement is significant for investors looking to maximize their income through dividend investments. Details of the Distribution The Board of...

Continue Reading
EQT Corporation Extends Exchange Offers and Consent Solicitations

Updated Category News Views 161

EQT Corporation Extends Exchange Offers and Consent Solicitations EQT Corporation (NYSE: EQT) recently revealed an important update regarding its exchange offers and consent solicitations. This announcement reflects the company’s commitment to providing clarity and opportunities for its stakeholders. The expiration date for these offers has been extended, showcasing...

Continue Reading
Middlefield U.S. Equity Dividend ETF Distributes Key Updates

Updated Category News Views 187

Recent Distributions from Middlefield U.S. Equity Dividend ETF Middlefield U.S. Equity Dividend ETF (TSX: MUSA) has exciting news regarding its distributions for unitholders. These distributions for the fourth quarter promise to benefit investors looking for reliable income through dividends. The Fund has announced a structured schedule that highlights key dates and...

Continue Reading
Bankruptcy Filing Announced for RUAB 'Alinita': Insights

Updated Category News Views 282

Bankruptcy Filing Announced for RUAB 'Alinita' The Panev?žys Regional Court, in a decisive ruling, has transitioned RUAB 'Alinita' into bankruptcy proceedings. This move follows the termination of its restructuring efforts which commenced on a specific date in the recent past. The company, part of the PST Group AB corporate structure, now finds itself looking toward a...

Continue Reading
Gold Prices Remain Strong Amid Fed Policy Concerns

Updated Category News Views 218

Gold Prices Maintain Strength as Market Eyes Federal Reserve Gold continues to command attention in the markets, currently trading close to $2,370. This performance is particularly notable as it stands just below a two-week high, attracting buyers due to its perceived safe-haven quality amid increasing concerns surrounding Federal Reserve's independence. Events...

Continue Reading